Voltaren 50 mg Filmtabletten

Voltaren is a widely recognized brand for pain relief, specifically containing the active ingredient diclofenac sodium. The brand was originally developed by Ciba-Geigy, a Swiss pharmaceutical company that later merged with Sandoz to form Novartis in 1996. The product shown in the image still features the Novartis logo, although ownership has evolved over time.

In 2022, Haleon was spun off from GSK (which had previously formed a consumer healthcare joint venture with Novartis) to become an independent global leader in consumer health. As of 2024 and beyond, Voltaren's over-the-counter (OTC) variants are primarily managed by Haleon, while prescription versions may still fall under different divisions. Manufacturing occurs across a global network of specialized pharmaceutical facilities to ensure supply to international markets.